Drug Pipeline

Kedrion IVIG 10% Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
2
Recruiting
4
Phase 3
1
Top Sponsors
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-30 NCT04944979
Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in Pediatric…
date change Primary completion pushed: 2026-04-30 -> 2026-12
2026-05-30 NCT04944979
Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in Pediatric…
date change Completion pushed: 2026-10-30 -> 2027-05
Active Studies by Phase
Phase 3
4
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07059000 A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic… Chronic Primary Immune Thrombocytopenia (ITP) Recruiting
NCT06752356 A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% in Subjects… Chronic Inflammatory Demyelinating Polyneuropathy Recruiting
NCT04944979 Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in Pediatric… Primary Immunodeficiency Disease Active, Not Recruiting
NCT07552987 A Study Investigating Intravenous Human Normal Immune Globulin 10% in Adults With Stiff… Stiff Person Syndrome Not Yet Recruiting
Sponsors Running Kedrion IVIG 10% Trials
Get alerts when Kedrion IVIG 10% trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free